Cargando…

Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice

Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. gra...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolati, Karim, Rakhshandeh, Hassan, Golestani, Mohsen, Forouzanfar, Fatemeh, Sadeghnia, Roya, Sadeghnia, Hamid R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Food Science and Nutrition 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047868/
https://www.ncbi.nlm.nih.gov/pubmed/30018891
http://dx.doi.org/10.3746/pnf.2018.23.2.127
_version_ 1783340004332797952
author Dolati, Karim
Rakhshandeh, Hassan
Golestani, Mohsen
Forouzanfar, Fatemeh
Sadeghnia, Roya
Sadeghnia, Hamid R.
author_facet Dolati, Karim
Rakhshandeh, Hassan
Golestani, Mohsen
Forouzanfar, Fatemeh
Sadeghnia, Roya
Sadeghnia, Hamid R.
author_sort Dolati, Karim
collection PubMed
description Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. graveolens (AGE) against potassium oxonate (PO)-induced hyperuricemia was investigated in mice. AGE (250, 500, and 1,000 mg/kg) or allopurinol (5 mg/kg, as positive control) were orally administrated 1 h after PO injection (250 mg/kg, ip) for two weeks. After that, the serum uric acid level and hepatic xanthine dehydrogenase (XDH) and xanthine oxidase (XO) activities were measured. In addition, the antioxidant activity of AGE was determined by assessment of hepatic lipid peroxidation, in vivo and the ferric reducing/antioxidant power assay, in vitro. The extract exhibited good capacity to reduce ferric ion to ferrous ion with mean value of 63.8±8.5 μmol/g. The data also showed that oxonate treatment produced a significant increase in serum uric acid level (4.6 vs. 2.3 mg/ dL, P<0.001), liver XO/XDH activities (P<0.01 and P<0.001, respectively), and hepatic lipid peroxides levels (about two fold, P<0.01), compared to the healthy mice. AGE significantly decreased the serum uric acid level, hepatic XO/XDH activities, and lipid peroxidation, in a dose-dependent manner. Oral administration of 1,000 mg/kg AGE for two weeks reversed the elevated serum uric acid level (2.7 vs. 4.6 mg/dL, P<0.001) and significantly inhibited liver XO/XDH activities (P<0.001) and diminished hepatic lipid peroxidation (0.45 vs. 0.82 nmol/mg protein, P<0.05), compared with hyperuricemic mice. AGE (1,000 mg/kg) per se did not significantly modify these parameters. Our results demonstrated that AGE could reduce the serum uric acid level via inhibition of hepatic XDH/XO and indicated its potential utility as an effective hypouricemic bioactive agent or functional food.
format Online
Article
Text
id pubmed-6047868
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Society of Food Science and Nutrition
record_format MEDLINE/PubMed
spelling pubmed-60478682018-07-17 Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice Dolati, Karim Rakhshandeh, Hassan Golestani, Mohsen Forouzanfar, Fatemeh Sadeghnia, Roya Sadeghnia, Hamid R. Prev Nutr Food Sci Articles Celery (Apium graveolens) is traditionally used to treat rheumatism and cardiovascular disorders. Hyperuricemia is considered as a predisposing factor for gout and is also suggested to be associated with coronary artery disease. In the present study, the effect of hydroalcoholic extracts from A. graveolens (AGE) against potassium oxonate (PO)-induced hyperuricemia was investigated in mice. AGE (250, 500, and 1,000 mg/kg) or allopurinol (5 mg/kg, as positive control) were orally administrated 1 h after PO injection (250 mg/kg, ip) for two weeks. After that, the serum uric acid level and hepatic xanthine dehydrogenase (XDH) and xanthine oxidase (XO) activities were measured. In addition, the antioxidant activity of AGE was determined by assessment of hepatic lipid peroxidation, in vivo and the ferric reducing/antioxidant power assay, in vitro. The extract exhibited good capacity to reduce ferric ion to ferrous ion with mean value of 63.8±8.5 μmol/g. The data also showed that oxonate treatment produced a significant increase in serum uric acid level (4.6 vs. 2.3 mg/ dL, P<0.001), liver XO/XDH activities (P<0.01 and P<0.001, respectively), and hepatic lipid peroxides levels (about two fold, P<0.01), compared to the healthy mice. AGE significantly decreased the serum uric acid level, hepatic XO/XDH activities, and lipid peroxidation, in a dose-dependent manner. Oral administration of 1,000 mg/kg AGE for two weeks reversed the elevated serum uric acid level (2.7 vs. 4.6 mg/dL, P<0.001) and significantly inhibited liver XO/XDH activities (P<0.001) and diminished hepatic lipid peroxidation (0.45 vs. 0.82 nmol/mg protein, P<0.05), compared with hyperuricemic mice. AGE (1,000 mg/kg) per se did not significantly modify these parameters. Our results demonstrated that AGE could reduce the serum uric acid level via inhibition of hepatic XDH/XO and indicated its potential utility as an effective hypouricemic bioactive agent or functional food. The Korean Society of Food Science and Nutrition 2018-06 2018-06-30 /pmc/articles/PMC6047868/ /pubmed/30018891 http://dx.doi.org/10.3746/pnf.2018.23.2.127 Text en Copyright © 2018 by The Korean Society of Food Science and Nutrition This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Dolati, Karim
Rakhshandeh, Hassan
Golestani, Mohsen
Forouzanfar, Fatemeh
Sadeghnia, Roya
Sadeghnia, Hamid R.
Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title_full Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title_fullStr Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title_full_unstemmed Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title_short Inhibitory Effects of Apium graveolens on Xanthine Oxidase Activity and Serum Uric Acid Levels in Hyperuricemic Mice
title_sort inhibitory effects of apium graveolens on xanthine oxidase activity and serum uric acid levels in hyperuricemic mice
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6047868/
https://www.ncbi.nlm.nih.gov/pubmed/30018891
http://dx.doi.org/10.3746/pnf.2018.23.2.127
work_keys_str_mv AT dolatikarim inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice
AT rakhshandehhassan inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice
AT golestanimohsen inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice
AT forouzanfarfatemeh inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice
AT sadeghniaroya inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice
AT sadeghniahamidr inhibitoryeffectsofapiumgraveolensonxanthineoxidaseactivityandserumuricacidlevelsinhyperuricemicmice